AZ-Oxford trials on Covid vaccine to resume in India

AZ-Oxford trials on Covid vaccine to resume in India

Days after AstraZeneca resumed trials on the AZ-Oxford University vaccine candidate against Covid-19, clinical trials will resume in India as well. The Drug Controller General of India (DCGI) has given its green signal to Serum Institute of India to resume trials on the Covid-19 vaccine candidate, with greater attention on screening and monitoring for adverse events. The vaccine trial had been paused in India after AZ had done the same globally, following an adverse event that was reported in one trial participant in the United Kingdom.

Read more at 
www.thehindubusinessline.com

Timeline

.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........

In-depth coverage

Read more top Business stories on Crisp